CXCR4 and breast cancer: Once the minimum length oligosaccharide was determined, in vivo experiments were designed to investigate the antagonistic effects of these oligosaccharides when compared to polymeric heparin on the haematological metastasis of CXCR4 expressing breast cancer cells.